Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Annina Grädel works together with painter-printmaker and video-artist to create an artwork that reflects T-cells in the thymus

As part of a public engagement project at the Wellcome Trust Centre for Human Genetics, our Department offered one DPhil student the exciting opportunity to work together with a local artist from the Oxford Printmakers Co-op to create an artwork based on their research. Annina Grädel won the bid to take this project forward and worked together with painter-printmaker and video-artist Jonathan Moss. The result is a stunning lightbox - a reflection of T cells in the thymus.

It is fascinating to have the unique opportunity to see your own research through completely different eyes. The collaboration with Jonathan made me focus on the “raw information” that is conveyed in my graphs and images, rather than the technical details and analyses my work normally focuses on. - Annina Grädel

The T cells of the immune system are responsible for defending us against infections, but they need to learn not to attack our own body. They learn this in an organ called the thymus. When T cells fail to be tolerant to their own body, this leads to autoimmune disease. Annina studies the genetics of this tolerance mechanism. The lightbox is Jonathan's interpretation of Annina's work.

The project culminated in an exhibition of all the artworks at Fushion Arts Oxford with a day of family fun where children and adults could engage with artworks as well as table top science.

The artwork will be displayed in the Department and will also make another outing to be exhibited in the JR between 21st of January - 3rd of March 2017. More details about where will follow nearer the time.

To read a bit more about the collaboration, visit Jonathan's blog. You can also watch a video of the artwork here. We are very pleased to know that Jonathan has found so much inspiration in Annina's work that he is currently creating more artworks which he will exhibit in due course. 

Similar stories

Oxford gets £122m funding for healthcare research

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients. The funding was awarded to the two NIHR Biomedical Research Centres.

How do muscles make us strong? Find out at IF Oxford Science & Ideas Festival

If you've ever wondered about the role of the muscle, come and meet us at IF Oxford - the Oxford science and ideas Festival on Saturday 8th & 15th October, when our researchers will be challenging members of the public to play our "Muscle Switch" game and exploring why strength differs between us.

Study raises hope of pre-school type 1 diabetes screening programme

Researchers in Oxford have launched the first UK study in the general population to test for early markers of type 1 diabetes before children develop symptoms or need insulin.

Developmental dynamics of the neural crest–mesenchymal axis in creating the thymic microenvironment

A new paper from researchers at the Department of Paediatrics and the Nuffield Department of Clinical Neurosciences has shown that fibroblasts in the thymus, often considered simply as dull “structural” cells, are much more complex than previously thought.

Oxford scientist named Australian of the Year in the UK

The Oxford Vaccine Group’s Lead Statistician, Professor Merryn Voysey, received the prestigious Australian of the Year in the UK award at a gala dinner recently.

Angelman syndrome: first patient to receive potential therapy in Oxford

Things that seemed impossible, only a few years ago, are happening today. The first patient in Europe and one of the first in the world was injected with a potential treatment, GTX-102, in a phase I/II clinical trial in Oxford.